Literature DB >> 16507939

Pulmonary embolism after major abdominal surgery in gynecologic oncology.

Martin A Martino1, Elana Borges, Eva Williamson, Sylvia Siegfried, Alan B Cantor, Johnathan Lancaster, William S Roberts, Mitchel S Hoffman.   

Abstract

OBJECTIVE: To estimate the incidence and prognostic significance of postoperative pulmonary embolism after gynecologic oncology surgery.
METHODS: All patients who underwent gynecologic oncology surgery from June 2001 to June 2003 and received venous thromboembolism prophylaxis with only intermittent pneumatic compression and early ambulation were identified from our database. Patients were grouped by procedure (major/minor abdominal or nonabdominal surgery), diagnosis (malignant/nonmalignant), and cancer subtype. Groups were compared by chi2 analysis and logistic regression. Survival was studied with the Kaplan-Meier method and Mantel-Byar test.
RESULTS: A total of 1,373 surgical patients were identified over the 2-year period, including 839 major abdominal surgery cases and 534 minor abdominal surgery or nonabdominal surgery cases. Of the 839 patients, 507 had a diagnosis of cancer, and 332 were benign. The incidence of pulmonary embolism among cancer patients undergoing major abdominal surgery was 4.1% (21/507) compared with 0.3% (1/332) among patients undergoing major abdominal surgery with benign findings (P < .001, odds ratio [OR] 13.8, 95% confidence interval [CI] 1.9-102.1). The incidence of pulmonary embolism among patients undergoing minor/nonabdominal surgery was 0.4% (2/536). Cancer diagnosis and age more than 60 years were identified as risk factors for pulmonary embolism (P = .009, OR 0.31, 95% CI 0.13-0.74). One-year survival for patients with and those without pulmonary embolism were 48.0% +/- 12% and 77.0% +/- 2%, respectively.
CONCLUSION: Patients with cancer undergoing major abdominal surgery and using pneumatic compression for thromboembolic prophylaxis had a 14-fold greater odds of developing a pulmonary embolism compared with patients with benign disease. Randomized studies are needed to determine whether additional prophylactic measures may benefit this high-risk group of patients. LEVEL OF EVIDENCE: II-3.

Entities:  

Mesh:

Year:  2006        PMID: 16507939     DOI: 10.1097/01.AOG.0000200046.28199.ae

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  20 in total

1.  Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.

Authors:  Lauren S Prescott; Lisa M Kidin; Rebecca L Downs; David J Cleveland; Ginger L Wilson; Mark F Munsell; Alma Y DeJesus; Katherine E Cain; Pedro T Ramirez; Michael H Kroll; Charles F Levenback; Kathleen M Schmeler
Journal:  Int J Gynecol Cancer       Date:  2015-01       Impact factor: 3.437

2.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

3.  Factors associated with in-hospital pulmonary embolism after shoulder arthroplasty.

Authors:  Bradley L Young; Mariano E Menendez; Dustin K Baker; Brent A Ponce
Journal:  J Shoulder Elbow Surg       Date:  2015-05-12       Impact factor: 3.019

4.  Venous thromboembolism in women undergoing pelvic reconstructive surgery with mechanical prophylaxis alone.

Authors:  T Ignacio Montoya; Edgar L Leclaire; Susan H Oakley; Andrea K Crane; Alexandra Mcpencow; Sara Cichowski; David D Rahn
Journal:  Int Urogynecol J       Date:  2014-02-07       Impact factor: 2.894

Review 5.  Prevention of venous thromboembolism in gynecologic oncology surgery.

Authors:  Emma L Barber; Daniel L Clarke-Pearson
Journal:  Gynecol Oncol       Date:  2016-11-25       Impact factor: 5.482

Review 6.  Venous thromboembolic events in minimally invasive gynecologic surgery.

Authors:  Pedro T Ramirez; Alpa M Nick; Michael Frumovitz; Kathleen M Schmeler
Journal:  J Minim Invasive Gynecol       Date:  2013-07-11       Impact factor: 4.137

Review 7.  Venous thromboembolism prophylaxis.

Authors:  Jonathan Laryea; Bradley Champagne
Journal:  Clin Colon Rectal Surg       Date:  2013-09

8.  Risk factors for perioperative venous thromboembolism: A retrospective study in Japanese women with gynecologic diseases.

Authors:  Nao Suzuki; Norihito Yoshioka; Tatsuru Ohara; Noriyuki Yokomichi; Takafumi Nako; Namiko Yahagi; Suguru Igarashi; Yoichi Kobayashi; Misako Yoshimatsu; Kenji Takizawa; Yasuo Nakajima; Kazushige Kiguchi; Bunpei Ishizuka
Journal:  Thromb J       Date:  2010-11-07

9.  Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies.

Authors:  Kathleen M Schmeler; Ginger L Wilson; Katherine Cain; Mark F Munsell; Pedro T Ramirez; Pamela T Soliman; Alpa M Nick; Michael Frumovitz; Robert L Coleman; Michael H Kroll; Charles F Levenback
Journal:  Gynecol Oncol       Date:  2012-11-28       Impact factor: 5.482

Review 10.  Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?

Authors:  Philippe Debourdeau; Ismail Elalamy; Axelle de Raignac; Paul Meria; Jean Marc Gornet; Yahovi Amah; Wolfang Korte; Michel Marty; Dominique Farge
Journal:  Support Care Cancer       Date:  2008-08-15       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.